Clinical trial
Trial of a Novel Chitosan Hemostatic Sealant in the Management of Complicated Epistaxis
NCT00863356 is registered in ClinicalTrials.gov with HemCon Medical Technologies, Inc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Trial of a Novel Chitosan Hemostatic Sealant in the Management of Complicated Epistaxis
- Lead sponsor
- HemCon Medical Technologies, Inc
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 31, 2009
- Completion date
- June 30, 2009
- Enrollment
- 20 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.